Trials / Completed
CompletedNCT01568593
Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 93 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of the efficacy and safety of T2750 and Vismed® in the treatment of moderate to severe Dry Eye Syndrome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | T2750 | 1 drop in each eye 3 to 6 times daily during 84 days |
| DEVICE | Vismed | 1 drop in each eye 3 to 6 times daily during 84 days |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2012-04-02
- Last updated
- 2016-04-04
- Results posted
- 2014-10-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01568593. Inclusion in this directory is not an endorsement.